TLM Utility Nav

Capacity Building and Advocacy to Achieve Hepatitis C Virus Elimination

Description

Presenters engage stakeholders, including persons with HCV, to discuss key evidence-based, capacity-building models for increasing access to HCV care and treatment along with important advocacy work needed to achieve HCV elimination. This session highlights telemedicine and pharmacy-led models of HCV care and important advocacy work still needed to expand HCV treatment access.  

 

Journey Maps

Objectives

  • Describe evidence-based telemedicine models of HCV care and treatment.
  • Define and review pharmacist-based models of HCV care and treatment.
  • Discuss the patient perspective of barriers to HCV treatment in care settings.